ARTV
ARTV
NASDAQ · Biotechnology

Artiva Biotherapeutics Inc

$6.69
+0.25 (+3.88%)
As of Apr 1, 3:06 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +21.7% upside
Low Target $7.28
Average Target $8.14
High Target $10.62
Current Price $6.69
Current
$6.69
Target
$8.14
$7.28 $8.14 avg $10.62
Scenario Analysis
Bear Case
$7.28
8.8%
Low target
Base Case
$8.14
+21.7%
Avg target
Bull Case
$10.62
+58.7%
High target
Risk/Reward
6.7x
Highly favorable
Price in Context
52-Week High
$7.75
-13.7% from high
52-Week Low
$1.47
+355.1% from low
Target vs 52W High
$8.14
+5.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%